Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Serina Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 25 | 25 | 0 |
| Shares | 319.1K | 335.8K | +16.6K (+5.2%) |
| Value | $1.60M | $1.90M | +$305.0K (+19.1%) |
New holders (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 13,184 | $74.8K | 0.00% |
| Toronto Dominion Bank | 3,554 | $20.2K | 0.00% |
| FMR LLC | 1 | $8 | 0.00% |
Sold out (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| SBI Securities Co., Ltd. | 100 | $501 |
| Strategic Investment Solutions, Inc. | 4 | $20 |
| Trust Co of Vermont | 1 | $5 |